Hepatocarcinogenesis Is Supported by Sublethal Necroptosis Signaling
NF-κB activation in hepatocytes with low RIPK3 expression can trigger sublethal necrosome activation.
Related Articles
Targeting Senescence for Next-Generation Cancer Treatments
Summary:. Cellular senescence has paradoxical effects on cancer emergence, progression, and therapeutic response. We herein identify four lessons that emerged from studying senescence interaction with…
Phase-Separated Biomolecular Condensation in Cancer: New Horizons and Next Frontiers
Summary:. Beyond lipid membrane compartments, cells including cancer cells utilize various membraneless compartments, often termed biomolecular condensates, to regulate or organize key cellular processes underlying…
Accelerating Drug Development Using Spatial Multi-omics
Summary:. Spatial biology approaches enabled by innovations in imaging biomarker platforms and artificial intelligence–enabled data integration and analysis provide an assessment of patient and disease…
Pushing the Boundaries of Liquid Biopsies for Early Precision Intervention
Summary:. Liquid biopsies are emerging as powerful minimally invasive approaches that have the potential to solve several long-standing problems spanning the continuum of cancer care:…
Cell States in Cancer: Drivers, Passengers, and Trailers
Summary:. Cancer is traditionally perceived through a genetic lens, with therapeutic strategies targeting oncogenic driver mutations. We advocate an overarching framework recognizing tumors as comprising…
CD News | American Association for Cancer Research
MyProstateScore 2.0 (MPS2) proved more accurate at detecting prostate cancer than PSA and other biomarkers, researchers reported, sparing men more invasive testing, such as prostate…
Alectinib OK’d for NSCLC
Genentech’s alectinib (Alecensa) received FDA approval for adjuvant treatment of non–small cell lung cancer (NSCLC) in patients with ALK-positive disease. The decision was based on…
Advancing Cancer Interception
Summary:. Rapid advances in technology and therapeutics, along with better methods to discern who is at risk for cancer by genetic testing and other means,…
Dr. Xin Zhou: Sharing and exploring pediatric cancer survivorship data
Read the paper: https://doi.org/10.1158/2159-8290.CD-23-1441
Investigational Urine Test Better at Finding Prostate Cancer
MyProstateScore 2.0 (MPS2) proved more accurate at detecting prostate cancer than PSA and other biomarkers, researchers reported, sparing men more invasive testing, such as prostate…